Insurer MetLife's quarterly profit beats on rebound in investment income
Reuters
Published Nov 03, 2021 04:29PM ET
Updated Nov 03, 2021 05:36PM ET
(Reuters) -U.S. insurer MetLife Inc (NYSE:MET) blew past Wall Street estimates for third-quarter profit on Wednesday, as strong investment gains helped cushion a hit from coronavirus-related claims.
The company reported adjusted profit of $2.1 billion, or $2.39 per share compared to $1.6 billion, or $1.73 per share, a year earlier. Analysts on average had expected a profit of $1.74 per share, according to Refinitiv data.
Global life insurers have been benefiting from a rebound in investment income, helping them offset increased payouts related to the health crisis. Total variable investment income more than doubled to $1.41 billion from a year earlier.
"MetLife delivered another very strong quarter. Outstanding variable investment income more than offset elevated COVID claims..." Chief Executive Michel Khalaf said in a statement.
The New York-based insurer, which had earlier said that the worst of the pandemic was behind it, reported an 18% jump in net investment income to $5.57 billion on strong returns from private-equity investments.
Rival Prudential Financial Inc (NYSE:PRU) too had reported solid quarterly adjusted profit, driven by strong performances at the U.S. insurer's life and annuity units.
Adjusted earnings at Metlife's U.S. business fell 1%, while Asia clocked a 22% jump, helping offset weakness in Latin America, where its business was hurt by higher COVID-19-related claims.
Adjusted earnings in its U.S. group business took a $290 million hit from pandemic-related claims, a jump from $75 million in the prior quarter, due to a bigger share of COVID-19 deaths under age 65.
It reported net derivative losses of $218 million in the quarter ended Sept. 30. The insurer holds a book of derivatives to hedge against market volatility.
Such gains do not indicate the actual performance of the company, but reflect the effect of accounting rules, an issue that has occurred in some previous quarters too.
Metlife's shares rose 2.5% in extended trading.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.